Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Cellosaurus is database indexing available cell lines from various collections: American Type Culture Collection (ATCC), Bioresource Collection and Research Center, Taiwan (BCRC), Banco de Células do Rio de Janeiro (BCRJ), CellBank Australia (CBA), Collection of Cell Lines in Veterinary Medicine (CCLV), Cell Lines Service (CLS), Coriell, Drosophila Genomics Resource Center (DGRC), Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ), European Bank for induced pluripotent Stem Cells (EBiSC), European Collection of Authenticated Cell Cultures (ECACC), Interlab Cell Line Collection (ICLC), Institute for Fermentation Osaka (IFO), Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER) biobank, Japanese Collection of Research Bioresources (JCRB) Cell Bank, Kunming Cell Bank of Type Culture Collection (KCB), Korean Cell Line Bank (KCLB), Millipore, National Cell Bank of Iran (NCBI_Iran), National Cancer Institute - Developmental Therapeutics Program (NCI-DTP), NINDS Human Cell and Data Repository (NHCDR), NIH AIDS Reagent Program (NIH-ARP), NISES, RIKEN Bioresource Center Cell Bank (RCB), Royan Stem Cell Bank (RSCB), Tick Cell Biobank (TCB), Tohoku University cell line catalog (TKG), and Ximbio.
| Name | Proper Citation | Organism | Disease |
Comments |
Defining Citation | Category | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Panc 02.03 Resource Report Resource Website 10+ mentions |
RRID:CVCL_1633 | Homo sapiens (Human) | Pancreatic adenocarcinoma | Population: Caucasian., From: Johns Hopkins University School of Medicine; Baltimore; USA., Part of: NCI RAS program mutant KRAS cell line panel., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). |
PMID:9612602 PMID:18000365 PMID:20037478 PMID:22460905 PMID:22585861 PMID:25167228 PMID:25485619 PMID:25877200 PMID:26216984 PMID:26589293 PMID:27259358 PMID:27397505 PMID:28196595 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778 |
Cancer cell line | Female | PANC-02-03, Panc_02_03, Panc02.03, Panc 2.03, Panc2.03, Panc2_03, PANC 203, Panc203, PANC203, PANC0203, Panc0203 | CLO:CLO_0008374, EFO:EFO_0006466, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2553, BioGRID_ORCS_Cell_line:491, BioSample:SAMN03473181, BioSample:SAMN10987714, cancercelllines:CVCL_1633, Cell_Model_Passport:SIDM01139, ChEMBL-Cells:CHEMBL3307761, ChEMBL-Targets:CHEMBL612584, Cosmic:2009528, Cosmic:2434088, Cosmic-CLP:1298475, DepMap:ACH-000042, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1298475, GEO:GSM206527, GEO:GSM621891, GEO:GSM887494, GEO:GSM888576, GEO:GSM1024405, GEO:GSM1374810, GEO:GSM1670331, IARC_TP53:28226, LiGeA:CCLE_407, LINCS_LDP:LCL-1739, PharmacoDB:Panc02_03_1239_2019, PRIDE:PXD003198, PRIDE:PXD030304, Progenetix:CVCL_1633, PubChem_Cell_line:CVCL_1633, Wikidata:Q54937512 |
CVCL_1633 | 2026-08-29 04:55:41 | 15 | ||||
|
PANC 215 Resource Report Resource Website 1+ mentions |
RRID:CVCL_E286 | Homo sapiens (Human) | Pancreatic ductal adenocarcinoma | From: Johns Hopkins University School of Medicine; Baltimore; USA. | PMID:22753594 | Cancer cell line | Female | Panc215, Pa09C | Cosmic:1473090, Cosmic:1509855, Wikidata:Q54937538 |
CVCL_E286 | 2026-08-29 04:55:42 | 1 | ||||
|
PANC-1 Resource Report Resource Website 1000+ mentions |
RRID:CVCL_0480 | Homo sapiens (Human) | Pancreatic ductal adenocarcinoma | Caution: Additional TP53 mutation in c.815T>C indicated incorrectly in PubMed=1630814., Karyotypic information: Has lost chromosome Y., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: ENCODE project common cell types; tier 3., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: AKT genetic alteration cell panel (ATCC TCP-1029). |
PMID:1140870 PMID:1630814 PMID:1764370 PMID:6435863 PMID:7809022 PMID:7961102 PMID:8026879 PMID:8194712 PMID:8286197 PMID:9023415 PMID:9788440 PMID:10027410 PMID:11115575 PMID:11169957 PMID:11169959 PMID:11787853 PMID:12692724 PMID:12800145 PMID:14695172 PMID:15126341 PMID:15367885 PMID:15688027 PMID:15770730 PMID:16912165 PMID:18298655 PMID:18380791 PMID:18575732 PMID:19077451 PMID:20037478 PMID:20418756 PMID:21515691 PMID:21607521 PMID:22460905 PMID:22585861 PMID:23325432 PMID:25167228 PMID:25394408 PMID:25485619 PMID:25877200 PMID:26216984 PMID:26589293 PMID:26884312 PMID:27067801 PMID:27259358 PMID:28196595 PMID:29894427 PMID:30156359 PMID:30894373 PMID:31037374 PMID:31068700 PMID:31978347 PMID:32058723 PMID:32782605 |
Cancer cell line | Male | Panc-1, PANC.1, Panc 1, PanC1, Panc1, PANC1, Panc-1-P | BCGO:BCGO_0000122, BTO:BTO_0000304, CLO:CLO_0008381, CLO:CLO_0050102, EFO:EFO_0002713, MCCL:MCC:0000378, CLDB:cl3872, CLDB:cl3873, CLDB:cl3874, 4DN:4DNSRDQPS1VU, AddexBio:C0018010/4923, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CRL-1469, BCRC:60284, BCRJ:0201, BioGRID_ORCS_Cell_line:190, BioSample:SAMN01821587, BioSample:SAMN03472068, BioSample:SAMN05292439, BioSample:SAMN10987682, cancercelllines:CVCL_0480, CCRID:1101HUM-PUMC000023, CCRID:3101HUMSCSP535, CCRID:3101HUMTCHu98, CCRID:4201HUM-CCTCC00309, CCRID:5301HUM-KCB08009YJ, CCTCC:GDC0309, Cell_Model_Passport:SIDM00610, CGH-DB:180-1, CGH-DB:9267-4, ChEMBL-Cells:CHEMBL3307545, ChEMBL-Targets:CHEMBL614139, CLS:300228, Cosmic:707250, Cosmic:710864, Cosmic:724643, Cosmic:730533, Cosmic:753625, Cosmic:808171, Cosmic:868242, Cosmic:873000, Cosmic:913307, Cosmic:918054, Cosmic:922248, Cosmic:923171, Cosmic:932521, Cosmic:947397, Cosmic:948377, Cosmic:949235, Cosmic:968106, Cosmic:1006367, Cosmic:1108335, Cosmic:1122348, Cosmic:1198204, Cosmic:1299304, Cosmic:1320459, Cosmic:1366282, Cosmic:1477432, Cosmic:1518236, Cosmic:1534320, Cosmic:1571781, Cosmic:1609544, Cosmic:1644316, Cosmic:1768264, Cosmic:2434107, Cosmic:2546060, Cosmic:2664043, Cosmic:2755953, DepMap:ACH-000164, DSMZ:ACC-783, DSMZCellDive:ACC-783, ECACC:87092802, EGA:EGAS00001000610, ENCODE:ENCBS101NPD, ENCODE:ENCBS314FVF, ENCODE:ENCBS397PLZ, ENCODE:ENCBS399ENC, ENCODE:ENCBS425ENC, ENCODE:ENCBS465AAA, ENCODE:ENCBS466AAA, ENCODE:ENCBS467AAA, ENCODE:ENCBS470AAA, ENCODE:ENCBS492WPY, ENCODE:ENCBS556WYR, ENCODE:ENCBS729QZR, ENCODE:ENCBS761TKL, ENCODE:ENCBS808TSD, ENCODE:ENCBS830QHD, ENCODE:ENCBS945URM, GEO:GSM206532, GEO:GSM244423, GEO:GSM383934, GEO:GSM472938, GEO:GSM472939, GEO:GSM621900, GEO:GSM784698, GEO:GSM887501, GEO:GSM888583, GEO:GSM923421, GEO:GSM945246, GEO:GSM945261, GEO:GSM1022632, GEO:GSM1024411, GEO:GSM1374806, GEO:GSM1374807, GEO:GSM1374808, GEO:GSM1435699, GEO:GSM1435700, GEO:GSM1435701, GEO:GSM1588613, GEO:GSM1588625, GEO:GSM3333104, GEO:GSM3333105, GEO:GSM3333108, GEO:GSM3333109, IARC_TP53:317, IBRC:C10156, IZSLER:BS TCL 49, KCB:KCB 200788YJ, KCB:KCB 200809YJ, KCLB:21469, LiGeA:CCLE_087, LINCS_LDP:LCL-1726, Lonza:818, MetaboLights:MTBLS812, MetaboLights:MTBLS9283, NCBI_Iran:C556, PharmacoDB:PANC1_1246_2019, PRIDE:PXD002192, PRIDE:PXD003198, PRIDE:PXD032263, Progenetix:CVCL_0480, PubChem_Cell_line:CVCL_0480, RCB:RCB2095, SKY/M-FISH/CGH:2001, TKG:TKG 0606, TOKU-E:2865, Ubigene:YC-C130, Wikidata:Q54937550 |
CVCL_0480 | 2026-08-29 04:55:40 | 2881 | ||||
|
Panc 08.13 Resource Report Resource Website 1+ mentions |
RRID:CVCL_1638 | Homo sapiens (Human) | Pancreatic ductal adenocarcinoma | Population: Caucasian., From: Johns Hopkins University School of Medicine; Baltimore; USA., Part of: NCI RAS program mutant KRAS cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). |
PMID:9612602 PMID:14695172 PMID:16912165 PMID:18000365 PMID:20164919 PMID:20215515 PMID:22460905 PMID:22585861 PMID:22753594 PMID:25167228 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27259358 PMID:27397505 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778 |
Cancer cell line | Male | Panc 8.13, Panc-08.13, PANC-08-13, Panc_08_13, Panc08.13, Panc8.13, Panc-8_13, Panc-813, PANC 813, Panc813, PANC813, PANC0813, Panc0813, Pa14C, PL9, PL-9 | CLO:CLO_0008379, EFO:EFO_0006470, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2551, BioGRID_ORCS_Cell_line:189, BioSample:SAMN03472947, BioSample:SAMN10988145, cancercelllines:CVCL_1638, Cell_Model_Passport:SIDM01136, ChEMBL-Cells:CHEMBL3308777, ChEMBL-Targets:CHEMBL1075558, Cosmic:925347, Cosmic:949526, Cosmic:1198215, Cosmic:1198221, Cosmic:1473126, Cosmic:1509858, Cosmic:2434104, Cosmic-CLP:925347, DepMap:ACH-000417, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:925347, GEO:GSM206531, GEO:GSM621905, GEO:GSM784709, GEO:GSM827278, GEO:GSM887499, GEO:GSM888581, GEO:GSM1024410, GEO:GSM1374813, GEO:GSM1670334, LiGeA:CCLE_501, LINCS_LDP:LCL-1742, PharmacoDB:Panc08_13_1244_2019, PRIDE:PXD003198, PRIDE:PXD030304, Progenetix:CVCL_1638, PubChem_Cell_line:CVCL_1638, Wikidata:Q54937528 |
CVCL_1638 | 2026-08-29 04:55:37 | 9 | ||||
|
Panc 03.27 Resource Report Resource Website 10+ mentions |
RRID:CVCL_1635 | Homo sapiens (Human) | Pancreatic adenocarcinoma | Population: Caucasian., From: Johns Hopkins University School of Medicine; Baltimore; USA., Part of: TCGA-110-CL cell line panel., Part of: RAS genetic alteration cell panel (ATCC TCP-1031)., Part of: NCI RAS program mutant KRAS cell line panel., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). |
PMID:9612602 PMID:14695172 PMID:16912165 PMID:18000365 PMID:19305140 PMID:20037478 PMID:20164919 PMID:22460905 PMID:22585861 PMID:25167228 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26216984 PMID:26589293 PMID:27259358 PMID:27397505 PMID:28196595 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31395879 PMID:35839778 |
Cancer cell line | Female | Panc 3.27, Panc-03.27, PANC-03-27, Panc_03_27, Panc-3_27, PANC3.27, Panc3.27, Panc3_27, Panc-327, PANC 327, Panc327, PANC0327, Panc0327, PL11, PL-11 | CLO:CLO_0008376, EFO:EFO_0006467, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2549, BioGRID_ORCS_Cell_line:188, BioSample:SAMN03473169, BioSample:SAMN10988317, cancercelllines:CVCL_1635, Cell_Model_Passport:SIDM01138, ChEMBL-Cells:CHEMBL3308124, ChEMBL-Targets:CHEMBL1075557, Cosmic:925346, Cosmic:949522, Cosmic:1198222, Cosmic:2434102, Cosmic-CLP:925346, DepMap:ACH-000139, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:925346, GEO:GSM206528, GEO:GSM621904, GEO:GSM784705, GEO:GSM887496, GEO:GSM888578, GEO:GSM1024407, GEO:GSM1374811, GEO:GSM1670332, IARC_TP53:27226, LiGeA:CCLE_371, LINCS_LDP:LCL-1740, PharmacoDB:Panc03_27_1241_2019, PRIDE:PXD003198, PRIDE:PXD030304, Progenetix:CVCL_1635, PubChem_Cell_line:CVCL_1635, Wikidata:Q54937517 |
CVCL_1635 | 2026-08-29 04:55:40 | 11 | ||||
|
PathHunter CHO-K1 OPRD1 beta-arrestin Resource Report Resource Website 1+ mentions |
RRID:CVCL_KY68 | Cricetulus griseus (Chinese hamster) | Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal. | Spontaneously immortalized cell line | Female | DiscoverX:93-0400C2, Wikidata:Q54937928 |
cvcl_0214 | CVCL_KY68 | 2026-08-29 04:55:48 | 6 | ||||||
|
PathHunter U2OS OPRM1 Total GPCR Internalization Resource Report Resource Website 1+ mentions |
RRID:CVCL_LB02 | Homo sapiens (Human) | Osteosarcoma | Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal., Population: Caucasian. | Cancer cell line | Female | PathHunter OPRM1 Total GPCR Internalization U2OS | DiscoverX:93-0745C3, Wikidata:Q54938246 |
cvcl_0042 | CVCL_LB02 | 2026-08-29 04:55:47 | 2 | ||||
|
PathHunter U2OS OPRD1 beta-arrestin-1 Resource Report Resource Website 1+ mentions |
RRID:CVCL_LA96 | Homo sapiens (Human) | Osteosarcoma | Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal., Population: Caucasian. | Cancer cell line | Female | DiscoverX:93-1084C3, Wikidata:Q54938238 |
cvcl_0042 | CVCL_LA96 | 2026-08-29 04:55:47 | 2 | |||||
|
PathHunter U2OS OPRK1 beta-arrestin Resource Report Resource Website 1+ mentions |
RRID:CVCL_LA97 | Homo sapiens (Human) | Osteosarcoma | Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal., Population: Caucasian. | Cancer cell line | Female | DiscoverX:93-0234C3, Wikidata:Q54938239 |
cvcl_0042 | CVCL_LA97 | 2026-08-29 04:55:51 | 4 | |||||
|
PaTu 8902 Resource Report Resource Website 10+ mentions |
RRID:CVCL_1845 | Homo sapiens (Human) | Pancreatic adenocarcinoma | Population: Caucasian., Part of: NCI RAS program mutant KRAS cell line panel., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). |
PMID:8194712 PMID:8287116 PMID:10700188 PMID:11668190 PMID:15126341 PMID:15688027 PMID:22460905 PMID:25167228 PMID:25485619 PMID:25877200 PMID:26216984 PMID:26589293 PMID:27397505 PMID:28196595 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778 |
Cancer cell line | Female | PA-TU-8902, PATU-8902, PaTu8902, PATU8902, 8902, PaCL2 | BTO:BTO_0006485, CLO:CLO_0008382, EFO:EFO_0006729, CLDB:cl3860, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:191, BioSample:SAMN03473078, BioSample:SAMN10987803, cancercelllines:CVCL_1845, Cell_Model_Passport:SIDM00455, Cosmic:873004, Cosmic:948381, Cosmic:2434100, Cosmic-CLP:1298526, DepMap:ACH-000599, DSMZ:ACC-179, DSMZCellDive:ACC-179, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1298526, GEO:GSM206534, GEO:GSM887502, GEO:GSM888584, GEO:GSM1670336, IARC_TP53:2966, IARC_TP53:25073, LiGeA:CCLE_026, LINCS_LDP:LCL-1744, NCBI_Iran:C557, PharmacoDB:PATU8902_1236_2019, PRIDE:PXD030304, Progenetix:CVCL_1845, Wikidata:Q54938318 |
CVCL_1845 | 2026-08-29 04:55:48 | 26 | ||||
|
PAZ6 Resource Report Resource Website 1+ mentions |
RRID:CVCL_GS29 | Homo sapiens (Human) | Group: Patented cell line. |
PMID:9133667 PMID:18283285 PMID:22649407 PMID:25925588 |
Transformed cell line | Sex unspecified | Paz6, PAZ-6 | ABM:T0729, GEO:GSM1543670, GEO:GSM1543671, Wikidata:Q54938334 |
CVCL_GS29 | 2026-08-29 04:55:52 | 1 | |||||
|
PaTu 8988t Resource Report Resource Website 50+ mentions |
RRID:CVCL_1847 | Homo sapiens (Human) | Pancreatic adenocarcinoma | Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: ENCODE project common cell types; tier 3., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). |
PMID:1348891 PMID:10408907 PMID:10700188 PMID:11668190 PMID:15126341 PMID:15688027 PMID:20215515 PMID:22460905 PMID:22585861 PMID:25167228 PMID:25485619 PMID:25877200 PMID:26216984 PMID:26589293 PMID:27397505 PMID:28196595 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778 |
Cancer cell line | Female | PA-TU-8988T, PaTu8988t, PaTu8988T, PATU8988T, PaTu 8988 T, PaTu-8988t, PATU-8988T, PATU-T, PA-TU T, 8988T, PaCL4 | BTO:BTO_0005878, CLO:CLO_0008384, EFO:EFO_0005713, CLDB:cl3862, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:986, BioSample:SAMN03473157, BioSample:SAMN10988386, cancercelllines:CVCL_1847, Cell_Model_Passport:SIDM00453, ChEMBL-Cells:CHEMBL4295420, ChEMBL-Targets:CHEMBL4296488, CLS:305133, Cosmic:873006, Cosmic:948382, Cosmic:1524020, Cosmic:1995611, Cosmic:2046531, Cosmic:2434111, Cosmic-CLP:1240201, DepMap:ACH-000023, DSMZ:ACC-162, DSMZCellDive:ACC-162, EGA:EGAS00001000610, EGA:EGAS00001000978, ENCODE:ENCBS158AAA, GDSC:1240201, GEO:GSM206535, GEO:GSM385524, GEO:GSM385535, GEO:GSM816667, GEO:GSM827178, GEO:GSM887504, GEO:GSM888586, GEO:GSM16703371, IGRhCellID:PA-TU-8988T%20GEO, LiGeA:CCLE_005, LINCS_LDP:LCL-1746, PharmacoDB:PATU8988T_1238_2019, PRIDE:PXD030304, Progenetix:CVCL_1847, PubChem_Cell_line:CVCL_1847, Wikidata:Q54938330 |
CVCL_1847 | 2026-08-29 04:55:52 | 52 | ||||
|
PC-3M-1E8 Resource Report Resource Website 1+ mentions |
RRID:CVCL_G257 | Homo sapiens (Human) | Prostate carcinoma | Characteristics: High metastatic potential., Population: Caucasian. |
PMID:18060641 PMID:20388373 |
Cancer cell line | Male | PC-3M IE8, PC-3M-IE8, PC3M-1E8, PC3M-IE8, 1E8-H | cancercelllines:CVCL_G257, CCRID:1101HUM-PUMC000199, Wikidata:Q54938438 |
cvcl_9555 | CVCL_G257 | 2026-08-29 04:55:51 | 3 | |||
|
PC-3U Resource Report Resource Website 1+ mentions |
RRID:CVCL_0482 | Homo sapiens (Human) | Prostate carcinoma | Population: Caucasian. | Cancer cell line | Male | MCCL:MCC:0000381, cancercelllines:CVCL_0482, Wikidata:Q54938455 |
cvcl_0035 | CVCL_0482 | 2026-08-29 04:55:53 | 2 | |||||
|
PC 61-5-3 Resource Report Resource Website 1+ mentions |
RRID:CVCL_4550 | Mus musculus (Mouse) | Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981). | Hybridoma | PC 61 5.3, PC 61.5.3, PC615.3, PC 61 | CLO:CLO_0008390, CLO:CLO_0008391, CLDB:cl5246, ATCC:TIB-222, BCRC:60492, CCRID:3101ETCHYB52, CLS:305001, ECACC:88041902, IZSLER:BS Hy 23, Wikidata:Q54938379 |
cvcl_4032 | CVCL_4550 | 2026-08-29 04:55:50 | 1 | ||||||
|
PC-3-TxR/CxR Resource Report Resource Website 1+ mentions |
RRID:CVCL_ZX06 | Homo sapiens (Human) | Prostate carcinoma | Population: Caucasian. | PMID:29662635 | Cancer cell line | Male | cancercelllines:CVCL_ZX06, Wikidata:Q102114740 |
cvcl_zx05 | CVCL_ZX06 | 2026-08-29 04:55:53 | 1 | ||||
|
PC-3-Luc Resource Report Resource Website 1+ mentions Discontinued |
RRID:CVCL_J265 | Homo sapiens (Human) | Prostate carcinoma | Population: Caucasian. | Cancer cell line | Male | cancercelllines:CVCL_J265, JCRB:JCRB1406, JCRB:NIHS0656, Wikidata:Q54938415 |
cvcl_0035 | CVCL_J265 | 2026-08-29 04:55:52 | 2 | |||||
|
PC-3 Resource Report Resource Website 1000+ mentions Discontinued |
RRID:CVCL_0035 | Homo sapiens (Human) | Prostate carcinoma | Caution: There seem to be two distinct cell lines which were assigned NCBI_Iran catalog number C427., Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: JFCR39 cancer cell line panel., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). |
PMID:447482 PMID:571045 PMID:1873816 PMID:3335022 PMID:3518877 PMID:6244232 PMID:8104329 PMID:8687134 PMID:9018337 PMID:9331090 PMID:9460501 PMID:9823299 PMID:10687853 PMID:10700174 PMID:10702678 PMID:10754530 PMID:10972993 PMID:11135431 PMID:11172901 PMID:11304728 PMID:11414198 PMID:11416159 PMID:12606952 PMID:12725112 PMID:14518029 PMID:15486987 PMID:15748285 PMID:16957166 PMID:17088437 PMID:17254797 PMID:17440963 PMID:19372543 PMID:20164919 PMID:21432867 PMID:22068913 PMID:22275356 PMID:22336246 PMID:22347499 PMID:22384151 PMID:22460905 PMID:22628656 PMID:23671654 PMID:23856246 PMID:23933261 PMID:24279929 PMID:24504141 PMID:24670534 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26256267 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27377824 PMID:27397505 PMID:27807467 PMID:28196595 PMID:29194687 PMID:30244336 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31404090 PMID:31733513 PMID:31978347 PMID:32968452 PMID:35839778 PMID:38861359 |
Cancer cell line | Male | PC3, PC.3 | BTO:BTO_0001061, CLO:CLO_0008395, CLO:CLO_0051535, EFO:EFO_0002074, MCCL:MCC:0000380, CLDB:cl3881, CLDB:cl3883, Abcam:ab275472, AddexBio:C0019002/61, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1435, ATCC:CRL-7934, BCRC:60122, BCRJ:0269, BioGRID_ORCS_Cell_line:193, BioSample:SAMN01821588, BioSample:SAMN01821653, BioSample:SAMN01821713, BioSample:SAMN03472063, BioSample:SAMN05292438, BioSample:SAMN10988356, cancercelllines:CVCL_0035, CCRID:1101HUM-PUMC000115, CCRID:3101HUMSCSP532, CCRID:3101HUMTCHu158, CCRID:4201HUM-CCTCC00095, CCTCC:GDC0095, Cell_Model_Passport:SIDM00088, ChEMBL-Cells:CHEMBL3307570, ChEMBL-Targets:CHEMBL390, CLS:300312, Cosmic:688118, Cosmic:704849, Cosmic:713868, Cosmic:719680, Cosmic:721366, Cosmic:721556, Cosmic:755297, Cosmic:759894, Cosmic:801350, Cosmic:809225, Cosmic:850414, Cosmic:869157, Cosmic:873002, Cosmic:875892, Cosmic:876396, Cosmic:897455, Cosmic:905934, Cosmic:911997, Cosmic:918502, Cosmic:920968, Cosmic:921048, Cosmic:922551, Cosmic:923957, Cosmic:943175, Cosmic:948379, Cosmic:949249, Cosmic:974299, Cosmic:1028650, Cosmic:1028702, Cosmic:1071477, Cosmic:1075273, Cosmic:1092627, Cosmic:1172628, Cosmic:1175888, Cosmic:1188436, Cosmic:1212489, Cosmic:1219448, Cosmic:1305380, Cosmic:1312367, Cosmic:1330910, Cosmic:1436048, Cosmic:1689714, Cosmic:1995613, Cosmic:1998469, Cosmic:2301588, Cosmic:2580130, Cosmic:2585153, Cosmic:2585230, Cosmic:2621167, Cosmic:2651772, Cosmic:2669172, Cosmic:2674178, Cosmic-CLP:905934, DepMap:ACH-000090, DSMZ:ACC-465, DSMZCellDive:ACC-465, ECACC:90112714, EGA:EGAS00001000610, EGA:EGAS00001000978, ENCODE:ENCBS420VDY, ENCODE:ENCBS451OVM, ENCODE:ENCBS504WVV, ENCODE:ENCBS596CTT, ENCODE:ENCBS608AAA, ENCODE:ENCBS609AAA, FANTOM5_SSTAR:10439-106E7, FCS-free:16-2-16-3-6-4, GDSC:905934, GEO:GSM2171, GEO:GSM50225, GEO:GSM50289, GEO:GSM91930, GEO:GSM142459, GEO:GSM142460, GEO:GSM482670, GEO:GSM525804, GEO:GSM595615, GEO:GSM648823, GEO:GSM743480, GEO:GSM750835, GEO:GSM784792, GEO:GSM799370, GEO:GSM799433, GEO:GSM844674, GEO:GSM844675, GEO:GSM847110, GEO:GSM887506, GEO:GSM888588, GEO:GSM1153442, GEO:GSM1178542, GEO:GSM1178543, GEO:GSM1181274, GEO:GSM1181303, GEO:GSM1374817, GEO:GSM1374818, GEO:GSM1670339, GEO:GSM2124647, GEO:GSM4962583, GEO:GSM4962584, GEO:GSM4962585, GEO:GSM4962586, GEO:GSM4962587, GEO:GSM4962588, GEO:GSM4962589, GEO:GSM4962590, GEO:GSM4962591, GEO:GSM7701363, GEO:GSM7701364, Hysigen:TCH-C297, IARC_TP53:752, IARC_TP53:21276, ICLC:HTL97018, IZSLER:BS TCL 175, JCRB:JCRB9110, KCB:KCB 200725YJ, KCLB:21435, LiGeA:CCLE_525, LINCS_HMS:50454, LINCS_LDP:LCL-1299, Lonza:125, MeSH:D000078722, NCBI_Iran:C427, NCI-DTP:PC-3, PharmacoDB:PC3_1248_2019, PRIDE:PRD000228, PRIDE:PRD000597, PRIDE:PXD000661, PRIDE:PXD002107, PRIDE:PXD003105, PRIDE:PXD003539, PRIDE:PXD005940, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD008184, PRIDE:PXD030304, PRIDE:PXD032264, Progenetix:CVCL_0035, PubChem_Cell_line:CVCL_0035, RCB:RCB2145, SKY/M-FISH/CGH:2799, TKG:TKG 0600, TOKU-E:2868, Ubigene:YC-C010, Wikidata:Q7118483 |
CVCL_0035 | 2026-08-29 04:55:52 | 4313 | ||||
|
PC-3-Luc2 Resource Report Resource Website 1+ mentions |
RRID:CVCL_A4BV | Homo sapiens (Human) | Prostate carcinoma | Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CRL-1435-LUC2)., Population: Caucasian. | Cancer cell line | Male | ATCC:CRL-1435-LUC2, cancercelllines:CVCL_A4BV, Wikidata:Q105510539 |
cvcl_0035 | CVCL_A4BV | 2026-08-29 04:55:53 | 3 | |||||
|
PC-12 Resource Report Resource Website 1+ mentions |
RRID:CVCL_S979 | Homo sapiens (Human) | Lung papillary adenocarcinoma | Population: Japanese., From: Immuno-Biological Laboratories (IBL); Tokyo; Japan. |
PMID:758928 PMID:3731100 |
Cancer cell line | Sex unspecified | PC 12, PC12 | CLS:500311, Hysigen:TCR-C615, Wikidata:Q54938388 |
CVCL_S979 | 2026-08-29 04:55:50 | 1 |
Can't find your Cell Line?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. If you want to find a specific cell line, it's easier to enter an RRID or add the vendor information to search. You can refine the search results using Facets on the left side of the search results page. If you are on the table view, you can also search in a specific column by clicking the column title and enter the keywords.
If you still could not find your cell line in the search results, please help us by registering it into the system — it's easy. Register it with the Cellosaurus. An RRID will be generated in 1-2 business days.
Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
